IMPORTANT NOTICE: The most up to date information is available on our HTML feed. To access please use the SPC links on the right hand side of the screen.
All content updates in below listings will resume by 01 April 2019.


600/200/24 milligram(s) Film-coated tablet

Bristol-Myers Squibb Pharmaceuticals ucEU/1/07/430/001

Main Information

Trade NameAtripla
Active SubstancesTenofovir disoproxil fumarate
Strength600/200/24 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderBristol-Myers Squibb Pharmaceuticals uc
Licence NumberEU/1/07/430/001

Group Information

ATC CodeJ05AR Antivirals for treatment of HIV infections, combinations
J05AR06 emtricitabine, tenofovir disoproxil and efavirenz


Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back